MCP-3522: IMMUNOASSAY INSTRUMENTS

Global Immunoassay Instruments Market to Exceed $7.1 Billion by 2010, According to New Report by Global Industry Analysts, Inc.

Global immunoassay instruments market is projected to cross $7.1 billion by 2010. Ageing population and technological advancements in healthcare industry is steadily expanding immunodiagnostics market, which in turn is driving the overall immunoassay instruments market. Economic improvements in the developing nations are also contributing to the growth.

San Jose, California (PRWEB), April 28, 2008 -- Immunoassay and hematology markets have recorded significant growth in recent years due to the innovation of new technologies and introduction of new products. New tests are being developed by manufacturers to survive in the industry. Some of the new tests such as utilization of cardiac markers especially troponin has stimulated growth in the industry. Players in the industry are expected to continue aggressive investments in research development and innovation of new technology and systems. Broad range of tests such as cancer, cardiac, endocrine, infectious diseases widely use immunoassay systems.

New software tools and hybridization techniques are also major driving factors in the industry. As a result, there is a surging demand for analytical and diagnostic laboratory instruments, test kits and assays. Due to their high specificity and sensitivity, immunoassays are suitable for detecting small amount of antigens present in a sample. Furthermore, identification of new disease states is also expanding the global market for immunoassays. Immunoassay instruments market worldwide is projected to grow at a modest pace and surpass $7.1 billion by 2010. Enzyme immunoassay market in Europe is forecasted to reach $1.24 billion by the year 2012.

Fluorescence immunoassay systems market in Asia-Pacific is projected to grow at a CAGR of 4.73% over the years 2011 through 2015, as stated by Global Industry Analysts, Inc.

A major trend affecting the healthcare industry is the consolidation of hospitals and laboratories driven by their efforts to reduce service and maintenance costs. The trend is more pronounced in Europe and is leading to the development of hub-spoke-satellite laboratory network. The trend is driving demand for total solution instruments and services, thereby creating renewed demand for diagnostic and analytical laboratory equipment such as immunoassay instruments. The consolidation drive is triggering standardization of instruments, reagents, instrument technologies and user interfaces.

Key players in immunoassay instruments market include Abbott Laboratories, Beckman Coulter Inc, bioMérieux, Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc, Roche Diagnostics and Siemens Healthcare Diagnostics.

The report titled “Immunoassay Instruments: A Global Strategic Business Report” published by Global Industry Analysts, Inc., presents detailed analyses and coverage of the US, Canadian, Japanese, European, Asia-Pacific, and Latin American markets. The report details major trends and issues in the immunoassay instruments market. Product segments independently analyzed for the above mentioned markets include enzyme immunoassay systems, fluorescence immunoassay systems, chemiluminescence immunoassay systems, radio immunoassay systems, and nephelometric immunoassay systems.

» Click here to view full details of the report

« Back